$DYAI
Dyadic International Inc

2019 Q4 Form 10-Q Financial Statement

#000121380919000074 Filed on November 13, 2019

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2018 Q3
Revenue $430.0K $454.5K $263.0K
YoY Change -37.68% 72.84% -2.61%
Cost Of Revenue $420.0K $384.8K $243.4K
YoY Change -17.65% 58.09% 10.64%
Gross Profit $10.00K $69.70K $19.55K
YoY Change -94.44% 256.47% -60.89%
Gross Profit Margin 2.33% 15.34% 7.44%
Selling, General & Admin $1.160M $1.060M $1.020M
YoY Change -9.38% 3.92% -9.73%
% of Gross Profit 11600.0% 1520.72% 5216.32%
Research & Development $780.0K $841.3K $476.6K
YoY Change 21.88% 76.52% -39.67%
% of Gross Profit 7800.0% 1207.02% 2437.52%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.950M $841.3K $476.6K
YoY Change 1.56% 76.52% -75.18%
Operating Profit -$1.940M -$1.943M -$1.781M
YoY Change 11.49% 9.11% -4.75%
Interest Expense $210.0K $245.0K $241.6K
YoY Change -8.7% 1.4% 27.18%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.730M -$1.700M -$1.540M
YoY Change 13.82% 10.39% -8.33%
Income Tax $10.00K $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.740M -$1.698M -$1.539M
YoY Change 241.18% 10.32% 1.95%
Net Earnings / Revenue -404.65% -373.68% -585.45%
Basic Earnings Per Share
Diluted Earnings Per Share -$63.76K -$62.55K -$55.46K
COMMON SHARES
Basic Shares Outstanding 27.21M shares 27.11M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q4 2019 Q3 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $34.22M $35.46M $42.52M
YoY Change -16.94% -16.6% -11.95%
Cash & Equivalents $4.824M $4.662M $1.715M
Short-Term Investments $29.40M $30.79M $40.80M
Other Short-Term Assets $100.0K $80.00K $660.0K
YoY Change -76.74% -87.88% -42.61%
Inventory
Prepaid Expenses
Receivables $558.5K $418.9K $200.0K
Other Receivables $750.0K $500.0K $320.0K
Total Short-Term Assets $35.64M $36.46M $43.69M
YoY Change -16.63% -16.56% -12.86%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.510M $1.510M $0.00
YoY Change -100.0%
Other Assets $51.31K $50.23K $50.00K
YoY Change -1.58% 0.46% -87.18%
Total Long-Term Assets $1.813M $2.065M $60.00K
YoY Change 228.04% 3341.67% -97.79%
TOTAL ASSETS
Total Short-Term Assets $35.64M $36.46M $43.69M
Total Long-Term Assets $1.813M $2.065M $60.00K
Total Assets $37.45M $38.52M $43.75M
YoY Change -13.51% -11.95% -17.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $943.4K $713.4K $540.0K
YoY Change 205.24% 32.11% -39.33%
Accrued Expenses $566.0K $470.1K $240.0K
YoY Change 41.65% 95.88% 41.18%
Deferred Revenue $78.64K $93.28K
YoY Change -44.22%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.588M $1.277M $840.0K
YoY Change 86.91% 52.0% -21.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.588M $1.277M $840.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.590M $1.280M $840.0K
YoY Change 87.06% 52.38% -21.5%
SHAREHOLDERS EQUITY
Retained Earnings -$41.35M -$39.61M
YoY Change 25.14%
Common Stock $39.61K $39.47K
YoY Change 1.66%
Preferred Stock
YoY Change
Treasury Stock (at cost) $18.93M $18.90M
YoY Change 0.16%
Treasury Stock Shares
Shareholders Equity $35.86M $37.24M $42.91M
YoY Change
Total Liabilities & Shareholders Equity $37.45M $38.52M $43.75M
YoY Change -13.51% -11.95% -17.23%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2018 Q3
OPERATING ACTIVITIES
Net Income -$1.740M -$1.698M -$1.539M
YoY Change 241.18% 10.32% 1.95%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$1.400M -$1.540M -$800.0K
YoY Change 13.82% 92.5% -34.96%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $1.340M $1.270M $1.230M
YoY Change -29.84% 3.25% -123.65%
Cash From Investing Activities $1.340M $1.270M $1.230M
YoY Change -29.84% 3.25% -123.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 220.0K 180.0K -1.930M
YoY Change -109.33% 19200.0%
NET CHANGE
Cash From Operating Activities -1.400M -1.540M -800.0K
Cash From Investing Activities 1.340M 1.270M 1.230M
Cash From Financing Activities 220.0K 180.0K -1.930M
Net Change In Cash 160.0K -90.00K -1.500M
YoY Change -76.47% -94.0% -76.71%
FREE CASH FLOW
Cash From Operating Activities -$1.400M -$1.540M -$800.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001213809
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Entity Address Address Line1
EntityAddressAddressLine1
140 Intracoastal Pointe Drive
dei Document Type
DocumentType
10-Q
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 404
dei Entity Address City Or Town
EntityAddressCityOrTown
Jupiter
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017Q2 dyai Collaborative Arrangement Duration Of Agreement
CollaborativeArrangementDurationOfAgreement
P2Y
CY2016Q1 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P1Y
CY2017Q3 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P1Y
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55264
dei Entity Registrant Name
EntityRegistrantName
DYADIC INTERNATIONAL, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-0486747
dei Entity Address Address Line1
EntityAddressAddressLine1
140 Intracoastal Pointe Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 404
dei Entity Address City Or Town
EntityAddressCityOrTown
Jupiter
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33477
dei City Area Code
CityAreaCode
561
dei Local Phone Number
LocalPhoneNumber
743-8333
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
DYAI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27213157 shares
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4662327 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2386314 USD
CY2019Q3 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
30793472 USD
CY2018Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
38816441 USD
CY2019Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
235440 USD
CY2018Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
294240 USD
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
418945 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
318744 USD
CY2019Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
9406 USD
CY2018Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
506866 USD
CY2019Q3 dyai Prepaid Researchand Developmentin Process Current
PrepaidResearchandDevelopmentinProcessCurrent
0 USD
CY2018Q4 dyai Prepaid Researchand Developmentin Process Current
PrepaidResearchandDevelopmentinProcessCurrent
253446 USD
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
336868 USD
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
172001 USD
CY2019Q3 us-gaap Assets Current
AssetsCurrent
36456458 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
42748052 USD
CY2019Q3 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
1514153 USD
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
309060 USD
CY2018Q4 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
0 USD
CY2019Q3 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
500616 USD
CY2018Q4 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
500616 USD
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
50232 USD
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
52139 USD
CY2019Q3 us-gaap Assets
Assets
38521459 USD
CY2018Q4 us-gaap Assets
Assets
43300807 USD
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
713395 USD
CY2019Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
470117 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
399576 USD
CY2019Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
93276 USD
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
141002 USD
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1276788 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
849638 USD
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39466659 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38966988 shares
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27213157 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26713486 shares
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
39467 USD
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
38967 USD
CY2019Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
95747666 USD
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
94385230 USD
CY2018Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
12253502 shares
CY2019Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
12253502 shares
CY2019Q3 us-gaap Treasury Stock Value
TreasuryStockValue
18929915 USD
CY2018Q4 us-gaap Treasury Stock Value
TreasuryStockValue
18929915 USD
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39612547 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33043113 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
37244671 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
42451169 USD
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
38521459 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
43300807 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
454507 USD
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
262960 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1247908 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
608576 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
384803 USD
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
243406 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1034934 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
519331 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
841343 USD
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
476633 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2351953 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1654716 USD
CY2019Q3 dyai Researchand Development Expense Related Party
ResearchandDevelopmentExpenseRelatedParty
101849 USD
CY2018Q3 dyai Researchand Development Expense Related Party
ResearchandDevelopmentExpenseRelatedParty
288175 USD
dyai Researchand Development Expense Related Party
ResearchandDevelopmentExpenseRelatedParty
827632 USD
dyai Researchand Development Expense Related Party
ResearchandDevelopmentExpenseRelatedParty
1021573 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1056196 USD
us-gaap Costs And Expenses
CostsAndExpenses
8594153 USD
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1023606 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4354941 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3238145 USD
CY2019Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-13727 USD
CY2018Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-12279 USD
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-24693 USD
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-1921 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
2397918 USD
CY2018Q3 us-gaap Costs And Expenses
CostsAndExpenses
2044099 USD
us-gaap Costs And Expenses
CostsAndExpenses
6435686 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1943411 USD
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1781139 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-7346245 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-5827110 USD
CY2019Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
245027 USD
CY2018Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
241644 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
777711 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
647686 USD
CY2019Q3 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-1698384 USD
CY2018Q3 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-1539495 USD
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-6568534 USD
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-5179424 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
900 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-1698384 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-1539495 USD
us-gaap Net Income Loss
NetIncomeLoss
-6569434 USD
us-gaap Net Income Loss
NetIncomeLoss
-5179424 USD
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.19
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
27181003 shares
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
27774436 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
26909205 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
27996754 shares
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
42451169 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1034346 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
328590 USD
us-gaap Net Income Loss
NetIncomeLoss
-6569434 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
37244671 USD
us-gaap Net Income Loss
NetIncomeLoss
-6569434 USD
us-gaap Net Income Loss
NetIncomeLoss
-5179424 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1034346 USD
us-gaap Share Based Compensation
ShareBasedCompensation
413640 USD
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
141362 USD
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
598464 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-24693 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1921 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-58800 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-176617 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
110807 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-66574 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-497460 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
0 USD
dyai Increase Decreasein Prepaid Researchand Development
IncreaseDecreaseinPrepaidResearchandDevelopment
-253446 USD
dyai Increase Decreasein Prepaid Researchand Development
IncreaseDecreaseinPrepaidResearchandDevelopment
-705836 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
164590 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
39732 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
429955 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
35345 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
70541 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
92616 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-47726 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
51786 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
6367452 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-102000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4381954 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3178357 USD
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
37585548 USD
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
39320144 USD
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
43953000 USD
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
40739000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1418856 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2304042 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
328590 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4500 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
328590 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2299542 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-38075 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-12600 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2276013 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4071643 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2386314 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5786348 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4662327 USD
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1714705 USD
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
506866 USD
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
0 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Use Of Estimates
UseOfEstimates
Use of EstimatesThe preparation of these consolidated financial statements in accordance with GAAP requires management to make estimates and judgments that affect the reported amount of assets and liabilities and related disclosure of contingent assets and liabilities at the date of our consolidated financial statements and the reported amounts of revenues and expenses during the applicable period. Actual results may differ from these estimates under different assumptions or conditions. Such differences could be material to the consolidated financial statements.
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
ConcentrationsThe Company’s financial instruments that are potentially subject to concentrations of credit risk consist primarily of cash and cash equivalents, and investment securities. At times, the Company has cash, cash equivalents, and investment securities at financial institutions exceeding the Federal Depository Insurance Company (“FDIC”) and the Securities Investor Protection Corporation (“SIPC”) insured limit on domestic currency and the Netherlands’ FDIC counterpart for foreign currency. The Company only deals with reputable financial institutions and has not experienced any losses in such accounts.
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
418945 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
318744 USD
CY2019Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
81320 USD
CY2018Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
91725 USD
CY2019Q3 us-gaap Prepaid Insurance
PrepaidInsurance
254997 USD
CY2018Q4 us-gaap Prepaid Insurance
PrepaidInsurance
77249 USD
CY2019Q3 us-gaap Prepaid Taxes
PrepaidTaxes
551 USD
CY2018Q4 us-gaap Prepaid Taxes
PrepaidTaxes
3027 USD
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
336868 USD
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
172001 USD
CY2019Q3 dyai Research And Development In Process Current
ResearchAndDevelopmentInProcessCurrent
636428 USD
CY2018Q4 dyai Research And Development In Process Current
ResearchAndDevelopmentInProcessCurrent
240064 USD
CY2019Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
17283 USD
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
0 USD
CY2019Q3 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
59684 USD
CY2018Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
68996 USD
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
713395 USD
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
309060 USD
CY2019Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
353552 USD
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
268287 USD
CY2019Q3 dyai Accrued Researchand Developmentin Process Current
AccruedResearchandDevelopmentinProcessCurrent
77855 USD
CY2018Q4 dyai Accrued Researchand Developmentin Process Current
AccruedResearchandDevelopmentinProcessCurrent
49666 USD
CY2019Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
38710 USD
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
81623 USD
CY2019Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
470117 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
399576 USD
dyai Research And Development Expense Facilities Overheadand Other
ResearchAndDevelopmentExpenseFacilitiesOverheadandOther
65456 USD
dyai Research And Development Expense Facilities Overheadand Other
ResearchAndDevelopmentExpenseFacilitiesOverheadandOther
60279 USD
CY2019Q3 dyai Research And Development Expense Outside Contracted Services
ResearchAndDevelopmentExpenseOutsideContractedServices
730190 USD
CY2018Q3 dyai Research And Development Expense Outside Contracted Services
ResearchAndDevelopmentExpenseOutsideContractedServices
365689 USD
dyai Research And Development Expense Outside Contracted Services
ResearchAndDevelopmentExpenseOutsideContractedServices
1974176 USD
dyai Research And Development Expense Outside Contracted Services
ResearchAndDevelopmentExpenseOutsideContractedServices
1316581 USD
CY2019Q3 dyai Research And Development Expense Contracted Services Related Party
ResearchAndDevelopmentExpenseContractedServicesRelatedParty
101849 USD
dyai Research And Development Expense Personnel Related Costs
ResearchAndDevelopmentExpensePersonnelRelatedCosts
277856 USD
CY2018Q3 dyai Research And Development Expense Contracted Services Related Party
ResearchAndDevelopmentExpenseContractedServicesRelatedParty
288175 USD
CY2019Q3 dyai Research And Development Expense Facilities Overheadand Other
ResearchAndDevelopmentExpenseFacilitiesOverheadandOther
15884 USD
CY2018Q3 dyai Research And Development Expense Facilities Overheadand Other
ResearchAndDevelopmentExpenseFacilitiesOverheadandOther
23637 USD
dyai Research And Development Expense Contracted Services Related Party
ResearchAndDevelopmentExpenseContractedServicesRelatedParty
827632 USD
dyai Research And Development Expense Contracted Services Related Party
ResearchAndDevelopmentExpenseContractedServicesRelatedParty
1021573 USD
CY2019Q3 dyai Research And Development Expense Personnel Related Costs
ResearchAndDevelopmentExpensePersonnelRelatedCosts
95269 USD
CY2018Q3 dyai Research And Development Expense Personnel Related Costs
ResearchAndDevelopmentExpensePersonnelRelatedCosts
87307 USD
dyai Research And Development Expense Personnel Related Costs
ResearchAndDevelopmentExpensePersonnelRelatedCosts
312321 USD
CY2019Q3 dyai Research And Development Expense Including Related Party
ResearchAndDevelopmentExpenseIncludingRelatedParty
943192 USD
CY2018Q3 dyai Research And Development Expense Including Related Party
ResearchAndDevelopmentExpenseIncludingRelatedParty
764808 USD
dyai Research And Development Expense Including Related Party
ResearchAndDevelopmentExpenseIncludingRelatedParty
3179585 USD
dyai Research And Development Expense Including Related Party
ResearchAndDevelopmentExpenseIncludingRelatedParty
2676289 USD
CY2017Q4 dyai Tax Cutsand Jobs Act Change In Alternative Minimum Tax Income Tax Benefit
TaxCutsandJobsActChangeInAlternativeMinimumTaxIncomeTaxBenefit
1001233 USD
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
500000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
900 USD
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2019Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2019Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
6900000 USD
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
4600000 USD
CY2018Q4 dyai Deferred Tax Assets Valuation Allowance Coverage Percent
DeferredTaxAssetsValuationAllowanceCoveragePercent
1
CY2019Q3 dyai Deferred Tax Assets Valuation Allowance Coverage Percent
DeferredTaxAssetsValuationAllowanceCoveragePercent
1
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4006390 shares
CY2018Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4006390 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3411890 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3411890 shares
CY2019Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
4662327 USD
CY2019Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
4662327 USD
CY2019Q3 us-gaap Investments And Cash
InvestmentsAndCash
36984818 USD
CY2019Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
30574 USD
CY2019Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
15708 USD
CY2019Q3 dyai Investmentsand Cash Amortized Cost
InvestmentsandCashAmortizedCost
36969952 USD
CY2018Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
2386314 USD
CY2018Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
2386314 USD
CY2018Q4 us-gaap Investments And Cash
InvestmentsAndCash
41117434 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
85321 USD
CY2018Q4 dyai Investmentsand Cash Amortized Cost
InvestmentsandCashAmortizedCost
41202755 USD
CY2017Q2 dyai Collaborative Arrangement Paymentfor Researchand Development Agreement
CollaborativeArrangementPaymentforResearchandDevelopmentAgreement
1100000 USD
CY2017Q2 dyai Collaborative Arrangement Paymentfor Researchand Development Agreement
CollaborativeArrangementPaymentforResearchandDevelopmentAgreement
1000000 EUR
CY2019Q3 dyai Prepaid Researchand Development
PrepaidResearchandDevelopment
0 USD
CY2018Q4 dyai Prepaid Researchand Development
PrepaidResearchandDevelopment
300000 USD
CY2019Q3 dyai Researchand Development Expense Related Party
ResearchandDevelopmentExpenseRelatedParty
100000 USD
CY2018Q3 dyai Researchand Development Expense Related Party
ResearchandDevelopmentExpenseRelatedParty
300000 USD
dyai Researchand Development Expense Related Party
ResearchandDevelopmentExpenseRelatedParty
800000 USD
dyai Researchand Development Expense Related Party
ResearchandDevelopmentExpenseRelatedParty
1000000.0 USD
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4006390 shares
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3552890 shares
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3552890 shares
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.57
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y21D
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1149461 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1089000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.26
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
635500 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.62
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4006390 shares
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.75
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y10M20D
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
17556185 USD
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2764073 shares
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.64
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y7M24D
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
12408351 USD
CY2019Q2 dyai Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Boardof Directors
SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofBoardofDirectors
3 board_of_director
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
635500 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.62
dyai Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisesin Period Net
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodNet
440000 shares
dyai Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisesin Period Common Stock
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodCommonStock
304171 shares
dyai Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisesin Period Forfeited
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodForfeited
135829 shares
dyai Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisesin Period Cash
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodCash
195500 shares
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
144180 USD
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
70620 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1034346 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
413640 USD
dyai Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisesin Period Common Stock Issued
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodCommonStockIssued
499671 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.62
dyai Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisesin Period Common Stock Issued
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodCommonStockIssued
0 shares
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
42451169 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
309563 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-2175258 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
40585474 USD
CY2019Q2 us-gaap Stock Issued1
StockIssued1
149180 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
580603 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-2695792 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
38619465 USD
CY2019Q3 us-gaap Stock Issued1
StockIssued1
179410 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
144180 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-1698384 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
37244671 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
49975264 USD
CY2018Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
374820 USD
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
269596 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-2043292 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
47826748 USD
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
73425 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-1596637 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
46303536 USD
CY2018Q3 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
1929222 USD
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
70619 USD
CY2018Q3 us-gaap Stock Issued1
StockIssued1
4500 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-1539495 USD
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
42909938 USD
CY2016Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
15000000 USD
CY2017Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
5000000 USD
CY2016Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
2136752 shares
CY2016Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
1.35
CY2016Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2884615 USD
CY2017Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
2363590 shares
CY2017Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
1.54
CY2017Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3639929 USD
CY2016Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
15000000 USD
CY2017Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
7863980 shares
CY2017Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
1.58
CY2017Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
12448283 USD
CY2017Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
2551717 USD
CY2017Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
5000000 USD
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
381607 shares
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
1.41
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
537661 USD
CY2017Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
4462339 USD
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1644325 shares
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
1.40
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2304042 USD
CY2018Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
2158297 USD
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
14390254 shares
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
1.52
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
21814530 USD
CY2019Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
12253502 shares
CY2018Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
12253502 shares
CY2019Q3 us-gaap Treasury Stock Value
TreasuryStockValue
18900000 USD
CY2018Q4 us-gaap Treasury Stock Value
TreasuryStockValue
18900000 USD

Files In Submission

Name View Source Status
0001213809-19-000074-index-headers.html Edgar Link pending
0001213809-19-000074-index.html Edgar Link pending
0001213809-19-000074.txt Edgar Link pending
0001213809-19-000074-xbrl.zip Edgar Link pending
dyai-20190930.htm Edgar Link pending
dyai-20190930.xsd Edgar Link pending
dyai-20190930_cal.xml Edgar Link unprocessable
dyai-20190930_def.xml Edgar Link unprocessable
dyai-20190930_g1.jpg Edgar Link pending
dyai-20190930_htm.xml Edgar Link completed
dyai-20190930_lab.xml Edgar Link unprocessable
dyai-20190930_pre.xml Edgar Link unprocessable
exhibit311certificatio.htm Edgar Link pending
exhibit312certificatio.htm Edgar Link pending
exhibit321sec1350certi.htm Edgar Link pending
exhibit322sec1350certi.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending